𝛼SK or Search

ENTITY

Imunon (IMNN US)

22

Analysis

Health Care • United States

IMUNON, Inc. operates as a clinical stage biotechnology company. The Company focuses on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON serves customers worldwide.

more

Refresh

Exchange Announcement • 29 Sep 2026 20:00

Current Report (Form 8-K | Period ending 2026-09-28)

Exchange Announcement • 12 Aug 2026 05:00

Current Report (Form 8-K | Period ending 2026-08-11)

Exchange Announcement • 11 Aug 2026 20:30

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 11 Aug 2026 20:01

Current Report (Form 8-K | Period ending 2026-08-11)

Exchange Announcement • 01 Jul 2026 04:30

Current Report (Form 8-K | Period ending 2026-06-29)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x